Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
Interim Analysis Expected End of 2Q 2025 BETHESDA, MD, Mar 14, 2025 – (ACN Newswire) – Gain Therapeutics, Inc. (Nasdaq: GANX)
Stay informed with the latest news updates on local and international events, current affairs, and stories that matter to the public.
Interim Analysis Expected End of 2Q 2025 BETHESDA, MD, Mar 14, 2025 – (ACN Newswire) – Gain Therapeutics, Inc. (Nasdaq: GANX)
MANILA, Mar 14, 2025 – (ACN Newswire) –Â Habitat for Humanity is excited to engage young people in the Asia-Pacific region
JAKARTA, Mar 13, 2025 – (ACN Newswire) – PT Wijaya Karya Bangunan Gedung Tbk (WEGE) a subsidiary of PT Wijaya Karya
WEGE & DEX Launch Netro: Indonesia’s Groundbreaking Net-Zero Smart Modular Home Concept Read Post »
Business NewsOverall Business Highlights: PHILIPPINES – iProov, a leading provider of science-based biometric identity solutions, today delivered its quarterly business update,
AUSTRALIA’S MOST PRESTIGIOUS DEVELOPERS HONOURED FOR EXCELLENCE IN DEVELOPMENT, DESIGN, AND SUSTAINABILITY MELBOURNE, Oct 15, 2024 – (ACN Newswire) – PropertyGuru